Form 8-K - Current report:
SEC Accession No. 0001829126-26-002460
Filing Date
2026-03-18
Accepted
2026-03-18 16:05:14
Documents
13
Period of Report
2026-03-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K voyageracq_8k.htm   iXBRL 8-K 73062
2 EXHIBIT 99.1 voyageracq_ex99-1.htm EX-99.1 20307
  Complete submission text file 0001829126-26-002460.txt   323043

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vachu-20260312.xsd EX-101.SCH 4203
4 XBRL DEFINITION FILE vachu-20260312_def.xml EX-101.DEF 27366
5 XBRL LABEL FILE vachu-20260312_lab.xml EX-101.LAB 38050
6 XBRL PRESENTATION FILE vachu-20260312_pre.xml EX-101.PRE 25986
16 EXTRACTED XBRL INSTANCE DOCUMENT voyageracq_8k_htm.xml XML 7020
Mailing Address C/O WINSTON & STRAWN LLP 800 CAPITOL ST., STE 2400 HOUSTON TX 77002
Business Address C/O WINSTON & STRAWN LLP 800 CAPITOL ST., STE 2400 HOUSTON TX 77002 03477204333
Voyager Acquisition Corp./Cayman Islands (Filer) CIK: 0002006815 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42211 | Film No.: 26768835
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)